Katie Halbmaier | University of Iowa Clinical Research and Trials

Attention Site Visitor

You are currently visiting the UI Health Care Clinical Trials website on a version of the web browser: Internet Explorer. Internet Explorer is no longer being supported by Microsoft, and there are features and functionality on this website that does not operate properly when using Internet Explorer. If you have an alternative browser, such as: Microsoft Edge, Google Chrome, Mozilla Firefox, or Apple Safari, we suggest you switch to that browser for the optimal viewing experience.

Thank you

Studies

Forest-CY 6022

Internal Medicine Adult Subjects Female Subjects Male Subjects

The purpose of this study is to collect long-term safety and tolerability data for aficamten.

ACACIA

Internal Medicine Adult Subjects Female Subjects Male Subjects

This clinical trial will study the effects of aficamten (versus placebo) on the quality of life, exercise capacity, and clinical outcomes of patients with non-obstructive hypertrophic cardiomyopathy.

DISCOVER-HCM (CV027-012)

Internal Medicine Heart and Vascular Heart Disease Adult Subjects Female Subjects Male Subjects